Wei Jia – författare

China is engaged in a major evolutionary economic change. Foreign direct investment (FDI) participation has been and will continue to be the driving force behind this change well into the next century. This book presents to Western business and legal communities a comprehensive picture of the prevailing Chinese foreign investment climate. More important, it provides keen insight into the ways China must move to improve its laws and policies.

Metabonomics - defined as the quantitative measurement of the multiparametric, time-related metabolic responses of a complex (multicellular) system to a pathophysiological intervention or genetic modification - is an effective tool for toxicological studies, potential biomarker identification of diseases, and identification of regulatory network pathways in plants and animals. Metabonomics is discussed in detail in many applications such as drug development, disease treatment and modernization of traditional Chinese medicine. This book covers research on metabonomics, ranging from the development of specialized chemical analytical techniques to the construction of databases and methods for metabolic simulation.The authors have been directly involved in the development of all the subject areas, including gas chromatography, liquid chromatography, mass spectrometry, metabolic databases, and metabolic simulation. Basic definition, breakthrough achievements and the future of metabonomic studies are described, making this book a valuable source for researchers in metabonomics in diverse fields such as animal, cellular, microbial, pharmaceutical, medical, and life sciences.

This monograph systematically delineates the cutting-edge advancements and clinical translational implications of metabolomics in modern medicine, encompassing its mechanistic and diagnostic applications in metabolic-endocrine disorders, malignancies (also with a focused analysis of gastrointestinal tumors), liver diseases, cardiovascular conditions, neuropsychiatric disorders, and immune-mediated illnesses. It further explores its utility in evaluating Traditional Chinese medicine efficacy, its synergistic integration with big data and artificial intelligence, and the trajectory of emerging technological innovations in the field. By addressing core methodological bottlenecks, data standardization imperatives, and reproducibility challenges, this work elucidates the irreplaceable role of metabolomics in advancing the precision medicine paradigm, distinct from genomics and proteomics, serving as a critical scholarly resource for researchers, clinicians, and graduate students.

This two-volume set, LNCS 15352 and LNCS 15353, constitutes the proceedings of the 18th Chinese Conference on Biometric Recognition, CCBR 2024, held in Nanjing, China, during November 22–24, 2024. The 52 full papers presented here were carefully reviewed and selected from 82 submissions.

This two-volume set, LNCS 15352 and LNCS 15353, constitutes the proceedings of the 18th Chinese Conference on Biometric Recognition, CCBR 2024, held in Nanjing, China, during November 22–24, 2024. The 52 full papers presented here were carefully reviewed and selected from 82 submissions.